ISSN: 2329-9096
Department of Pharmacology, Federal University of Paraná, Curitiba, PR, Brazil
 Research Article   
								
																Prevalence of Comorbidities in Patients with Psoriasis in Brazil: Preliminary Results of the Pharmacoepidemiological Study Pso.BRA 
																Author(s): Kauê Cézar Sá Justo, Aguinaldo Bonalumi FIlho, Fernando Henrique Teixeira Zonzini, Jessica Scherer Dagostini, Adriane Reichert Faria, Anber Ancel Tanaka, Daniela  Almeida Cabrini, João  B Calixto and Michel Fleith Otuki*             
								
																
						  Psoriasis is a chronic inflammatory skin disease with multisystem involvement and associated with multiple
  comorbidities. It is estimated that the disease affects up to 11.4% of adults. Several factors contribute to the
  development and worsening of psoriasis and the identification of these factors is important to individualize therapy
  and achieve better therapeutic results and the quality of life for these patients. However, epidemiological data are
  scarce, especially in Brazil, making clinical management difficult. The aim of the Pso.BRA study is to trace the
  pharmacoepidemiological profile of patients with psoriasis in Brazil. The pilot project included 97 patients over 18
  years of age, of both sexes, with psoriasis diagnosed at any level of severity treated at two outpatient psoriasis services
  located in Curitiba (Paraná, Brazil). Regarding sociodemogra.. View More»
						  
																DOI:
								10.35248/2329-9096.22.10.653